# Single source: Childhood Cancer Survivor Study (U24 Clinical Trial Not Allowed)

Source: https://welltoldgrants.com/grants/rfa-ca-26-011-single-source-childhood-cancer-survivor-study-u24-clinical/  
Official notice: https://www.grants.gov/search-results-detail/361534

> National Institutes of Health plans to offer grants to nonprofits. It is a forecast: the notice is expected around June 22, 2026, with applications due around September 25, 2026.

| Field | Value |
|---|---|
| Opportunity number | RFA-CA-26-011 |
| Agency | National Institutes of Health |
| Status | Forecast |
| Deadline | expected September 25, 2026 |
| Award ceiling | not stated |
| Award floor | not stated |
| Expected awards | not stated |
| Total funding | not stated |
| Cost sharing | not required |
| Assistance Listings | 93.395 |

## Who can apply

- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Others (see text field entitled "Additional Information on Eligibility" for clarification)

This is a non-competitive funding opportunity intended to fund a single award. Through this single source, cooperative agreement Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) solicits an application to fund a single award to the current recipient of the Childhood Cancer Survivor Study.

## What the grant funds

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) intends to support the continuation of the Childhood Cancer Survivor Study (CCSS) that investigates the long-term morbidity and mortality associated with cancer treatments. The CCSS represents a multi-institutional, multidisciplinary collaborative research resource that currently has health-related data from 38,000 or more 5-year survivors of pediatric and adolescent cancer patients with a comparison sibling control cohort. This NOFO seeks to obtain additional age-related longitudinal information from the current cohort of survivors and to include pediatric cancer survivors receiving modern therapies. The goal of the CCSS is to serve as a data resource and a biorepository for researchers. The objectives are to use the resources to conduct cancer risk assessments, observational and intervention-based research studies associated with long-term outcomes across the life span of survivors with the intent of improving cancer treatments. This is a Forecast for a single source that will invite application(s) from eligible organization(s) to apply. Please see the Eligibility Section for additional information. In accordance with NIH standard peer-review processes, the application(s) will be peer-reviewed, and only meritorious application(s) will be considered for funding.

## Questions people ask

### Is RFA-CA-26-011 still open?

Not yet. It is a forecast: expected deadline September 25, 2026.

### Who can apply for Single source: Childhood Cancer Survivor Study (U24 Clinical Trial Not Allowed)?

National Institutes of Health accepts applications from nonprofits. The notice adds further conditions, so read its eligibility section.

### What is the deadline for Single source: Childhood Cancer Survivor Study (U24 Clinical Trial Not Allowed)?

Expected deadline September 25, 2026. Confirm the date and time in the official notice on Grants.gov.

### Who has won Cancer Treatment Research grants before?

The largest recipients over five fiscal years were The Univeristy of Texas M.D. Anderson Cancer Center, Dana-Farber Cancer Institute, Inc., Icahn School of Medicine at Mount Sinai. The program made 3,622 awards worth $5.6 billion in that time.